Literature DB >> 2745415

Effect of N1,N12-bis(ethyl)spermine and related compounds on growth and polyamine acetylation, content, and excretion in human colon tumor cells.

A E Pegg1, R Wechter, R Pakala, R J Bergeron.   

Abstract

Exposure of human colon tumor (HT 29 cells) to N1,N12-bis(ethyl)spermine and analogs produced a rapid loss of intracellular polyamines. This loss was brought about predominantly by an increased excretion of spermidine. N1,N11-Bis(ethyl)norspermine and N1,N12-Bis(ethyl)spermine were potent inducers of spermidine/spermine N1-acetyltransferase, and this induction facilitated the efflux of polyamines by enhancing the conversion of spermine into spermidine. N1,N14-Bis(ethyl)homospermine, which did not induce spermidine/spermine N1-acetyltransferase, also caused the loss of spermidine from the cell but was less effective in bringing about the decline in intracellular spermine. These results indicate that cellular polyamine levels can be regulated by excretion of spermidine and that the bis(ethyl)spermine derivatives deplete intracellular polyamine content by interference with this process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2745415

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Regulation of the efflux of putrescine and cadaverine from rapidly growing cultured RAW 264 cells by extracellular putrescine.

Authors:  R R Tjandrawinata; C V Byus
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

2.  Effects of the S-adenosylmethionine decarboxylase inhibitor, 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine, on cell growth and polyamine metabolism and transport in Chinese hamster ovary cell cultures.

Authors:  T L Byers; R S Wechter; R H Hu; A E Pegg
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

3.  Phase 1 study of N1-N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignancies.

Authors:  R R Streiff; J F Bender
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

4.  Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines.

Authors:  B K Chang; R J Bergeron; C W Porter; J R Vinson; Y Liang; P R Libby
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Antitumor effects of N-alkylated polyamine analogues in human pancreatic adenocarcinoma models.

Authors:  B K Chang; R J Bergeron; C W Porter; Y Liang
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Phase I trial of the polyamine analog N1,N14-diethylhomospermine (DEHSPM) in patients with advanced solid tumors.

Authors:  George Wilding; David King; Kendra Tutsch; Marcia Pomplun; Chris Feierabend; Dona Alberti; Rhoda Arzoomanian
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

7.  Induction of spermidine/spermine N1-acetyltransferase activity in Chinese-hamster ovary cells by N1N11-bis(ethyl)norspermine (corrected) and related compounds.

Authors:  A E Pegg; R Pakala; R J Bergeron
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

8.  Investigations of the mechanism by which mammalian cell growth is inhibited by N1N12-bis(ethyl)spermine.

Authors:  L Albanese; R J Bergeron; A E Pegg
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

9.  Stable intracellular acidification upon polyamine depletion induced by alpha-difluoromethylornithine or N1,N12-bis(ethyl)spermine in L1210 leukaemia cells.

Authors:  R Poulin; A E Pegg
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

10.  Two polyamine analogs (BE-4-4-4 and BE-4-4-4-4) directly affect growth, survival, and cell cycle progression in two human brain tumor cell lines.

Authors:  C J Bergeron; H S Basu; L J Marton; D F Deen; M Pellarin; B G Feuerstein
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.